541
Views
17
CrossRef citations to date
0
Altmetric
Research Article

The PREVENT research programme – A novel research programme to identify and manage midlife risk for dementia: the conceptual framework

, &
Pages 748-754 | Received 13 Nov 2013, Accepted 21 Nov 2013, Published online: 15 Jan 2014

References

  • Artero, S., Tierney, M.C., Touchon, J. & Ritchie, K. (2003). Prediction of transition from cognitive impairment to senile dementia: A prospective, longitudinal study. Acta Psychiatrica Scandinavica, 107, 390–393.
  • Bateman, R.J., Xiong, C., Benzinger, T.L.S., Fagan, A.M., Goate, A., Fox, N.C., … Morris, J.C. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367, 795–804.
  • BISQ. (2011). Brain Injury Screening Questionnaire. New York: Brain Injury Research Center, Department of Rehabilitation Medicine, Mount Sinai Medical Center.
  • Borson, S., Frank, L., Bayley, P.J., Boustani, M., Dean, M., Lin, P.J., … Ashford, J.W. (2013). Improving dementia care: The role of screening and detection of cognitive impairment. Alzheimer's Dementia, 9, 151–159.
  • Bosch, J., Yusuf, S., Pogue, J., Sleight, P., Lonn, E., Rangoonwala, B., … Probstfield, J. (2002). Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: Double blind randomised trial. British Medical Journal, 324, 699–702.
  • Brayne, C. & Davis, D. (2013). Making Alzheimer's disease and Dementia research fit for populations. Lancet, 381 (9866), 533–534.
  • Buysse, D.J., Reynolds, C.F., Monk, T.H., Berman, S.R. & Kupfer, D.J. (1989). The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Research, 28, 193–213.
  • Connor, K.M. & Davidson, J.R. (2001). Connor–Davidson Resilience Scale (CD-RISC). Durham, NC: Duke University Medical Center.
  • Department of Health. (2013). Policy: Improving care for people with dementia. www.gov.uk/government/policies/improving-care-for-people-with-dementia.
  • Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Diehr, P., O’Meara, E.S., Longstreth, W.T. Jr & Luchsinger, J.A. (2009). Mid and late-life obesity: Risk of dementia in the cardiovasucular cognition study. Archives of Neurology, 66, 336–342.
  • Fox, N., Warrington, E. & Rossor, M. (1999). Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet, 353, 2125–2136.
  • Fratiglioni, L., Launer, L.J., Andersen, K., Breteler, M.M., Copeland, J.R., Dartigues, J.F., … Hofman, A. (2000). Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 54(11 suppl. 5), S10–15.
  • Gandy, S. (2005). The role of cerebral amyloid β accumulation in common forms of Alzheimer disease. Journal of Clinical Investigation, 115, 1121–1129.
  • Hulette, C.M., Welsh-Bohmer, K.A., Murray, M.G., Saunders, A.M., Mash, D.C. & McIntyre L.M. (1998). Neuropathological and neuropsychological changes in ‘normal’ aging; evidence for pre-clinical Alzheimer's disease in cognitively normal individuals. Journal of Neuropathology and Experimental Neurology, 57, 1168–1174.
  • Jack, C.R. Jr, Knopman, D.S., Jaqust, W.J., Peterson, R.C., Weiner, M.W., Aisen, P.S. & Trojanowski, J.Q. (2013). Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12, 207–216.
  • Kmietowicz, Z. (2012). Cameron launches challenge to end ‘national crisis’ of poor dementia care. British Medical Journal, 344, e2347.
  • Lambert, J.-C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A., Sims, R., Bellenguez C., … Amouyel, P. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics, doi:10.1038/ng.2802.
  • Le Couteur, D.G., Doust, J., Creasey, H. & Brayne, C. (2013). Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis. British Medical Journal, 347, f5125.
  • Matthews, F.E., Arthur, A., Barnes, L.E., Bond, J., Jagger, C., Robinson L. & Brayne, C. (2013). A two decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet, 382(9902), 1405–1412.
  • Milne, A. (2010). Dementia screening and early diagnosis: The case for and against. Health, Risk and Society, 12, 656–676.
  • Morris, M., Evans, D., Bienias, J., Tangney, C., Bennett, D., Aggarwal, N., … Wilson, R. (2003). Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology, 60, 194–200.
  • Morris, J. & Price, J. (2001). Pathologic correlates of nondemented aging, mild cognitive impairment and early stage Alzheimer's disease. Journal of Molecular Neuroscience, 17, 101–118.
  • Olichney, J.M., Yang, J.-C., Taylor, J. & Kutas, M. (2011). Cognitive event-related potentials: Biomarkers of synaptic dysfunction across the stages of Alzheimer's disease. Journal of Alzheimer's Disease, 26, 215–228.
  • Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A. & Breteler, M.M. (1999). Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology, 53, 1937–1942.
  • Parra, M.A., Abrahams, S., Logie, R.H., Mendez, L.G., Lopera, F. & Della Sala, S. (2010). Visual short-term memory binding deficits in familial Alzheimer’s disease. Brain, 133, 2702–2713.
  • Perrin, R.J., Craig-Schapiro, R., Malone, J.P., Shah, A.R., Gilmore, P., Davis, A.E., … Fagan, A.M. (2011). Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLOS ONE, 6, e16032.
  • Radloff, L.S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
  • Ravenni, R., Jabre, J. & Mazza, A. (2011). Primary stroke prevention and hypertension treatment: Which is the first-line strategy?Neurology International, 3, e12.
  • Ritchie, K. (1988). The screening of cognitive impairment in the elderly: A critical review of current methods. Journal of Clinical Epidemiology.41, 635–643.
  • Ritchie, K., Artero, S. & Touchon, J. (2001). Classification criteria for mild cognitive impairment: A population-based validation study. Neurology, 56, 37–42.
  • Ritchie, K., Carriére, I., Ritchie, C.W., Berr, C., Artero, S. & Ancelin, M.-L. (2010). Designing prevention programmes to reduce incidence of dementia: Prospective cohort study of modifiable risk factors. British Medical Journal, 341, c3885.
  • Ritchie, K. & Ritchie, C.W. (2012). The PREVENT study: A prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer’s disease. BMJ Open, 2(6), e001893.
  • Scottish Collaborative Group. (2004). Food Frequency Questionnaire. Aberdeen: University of Aberdeen.
  • Sofi, F., Macchi, C., Abbate, R., Gensini, G.F. & Casini, A. (2012). Effectiveness of the Mediterranean diet: Can it help delay or prevent Alzheimer's disease?Journal of Alzheimer's Disease, 20(3), 795–801.
  • Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. & Roses, A.D. (1993). Apolipoprotein E: High-avidity binding to beta- amyloid and increased frequency of type 4 allele in late- onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 90, 1977–1981.
  • Van de Flier, W.M. & Scheltens, P. (2005). Epidemiology and risk factors of dementia. Journal of Neurology, Neurosurgery and Psychiatry, 76, 2–7.
  • Wolfe, J. & Kimerling, R. (1997). Gender issues in the assessment of posttraumatic stress disorder. In J. Wilson & T.M. Keane (Eds), Assessing Psychological Trauma and PTSD (pp. 192–238). New York: Guilford.
  • Wang, J.Z., Xia, Y.Y., Grundke-Iqbal, I. & Iqbal, K. (2013). Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. Journal of Alzheimer's Disease, 33, S123–139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.